(Neo)adjuvant therapy for upper tract urothelial cancer | Dr Alison Birtle

(25:7)

Alison Birtle: ASCO GU highlights

(1:53)

Cancer Quality of Life Survey - Dr Alison Birtle

(1:13)

Talking Urology with Ian Davis and Alison Birtle

(6:39)

An important message from Alison Birtle, Trustee of and Medical Advisor of Fight Bladder Cancer

(45)

Best of GU 2019 - Alison Birtle on Pout via ZOOM

(22:20)

ANZUP in Conversation with Alison Birtle \u0026 Dickon Hayne #ANZUP2020

(22:45)

First Prize for the Best Abstract (Oncology) - EAU 2018

(1:45)

Uro-Onc data at ESMO 2018: what to look out for

(1:22)

Localized high-risk prostate cancer: updated results from 12-year follow up of GETUG-12

(1:17)

POUT trial: a new standard of care for upper tract urothelial carcinoma

(1:3)

ASCO GU 2021 highlights: enfortumab vedotin, oral docetaxel and 177Lu-PSMA-617

(50)

EMUC18: POUT trial

(4:40)

Alison Birtle Furness Charity Challenge Final 2012.m4v

(4:34)

Carboplatin Versus Cisplatin in UTUC

(10:40)

POUT: extended follow-up results

(10:5)

mCRPC: cabazitaxel re-challenge

(2:6)

POUT: Adjuvant Chemotherapy After Nephroureterectomy for Patients With UTUC

(8:16)

Alison birtle

(4:8)

QoL impact of cystectomy

(4:39)